The termination of action of catecholamines in the isolated venous tissue of the dog.
D000818:Animals; D001345:Autoradiography; D003042:Cocaine / Q000494:pharmacology; D004285:Dogs; D004336:Drug Antagonism; D004357:Drug Synergism; D004837:Epinephrine / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D006651:Histocytochemistry; D007099:Imipramine / Q000494:pharmacology; D007101:Immersion; D066298:In Vitro Techniques; D007490:Iproniazid / Q000494:pharmacology; D008996:Monoamine Oxidase Inhibitors; D009431:Neural Conduction / Q000187:drug effects; D009638:Norepinephrine / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D009821:Oils; D010477:Perfusion; D012501:Saphenous Vein / Q000166:cytology; D014316:Tritium; D014680:Veins / Q000378:metabolism*
D008996:Monoamine Oxidase Inhibitors; D009821:Oils; D014316:Tritium; D007490:Iproniazid; D003042:Cocaine; D007099:Imipramine; D009638:Norepinephrine; D004837:Epinephrine